X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs TEVA PHARMA (Israel) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN LTD
Mar-16
TEVA PHARMA
Dec-13
LUPIN LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,1272,714-   
Low Rs1,2942,358-   
Sales per share (Unadj.) Rs304.11,557.6-  
Earnings per share (Unadj.) Rs50.497.3-  
Cash flow per share (Unadj.) Rs60.7223.2-  
Dividends per share (Unadj.) Rs7.5085.18-  
Dividend yield (eoy) %0.43.4 13.1%  
Book value per share (Unadj.) Rs243.81,730.2-  
Shares outstanding (eoy) m450.58848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.61.6 345.5%   
Avg P/E ratio x33.926.1 130.2%  
P/CF ratio (eoy) x28.211.4 248.1%  
Price / Book Value ratio x7.01.5 478.7%  
Dividend payout %14.987.5 17.0%   
Avg Mkt Cap Rs m770,7402,150,341 35.8%   
No. of employees `00016.444.9 36.4%   
Total wages/salary Rs m21,0770-   
Avg. sales/employee Rs Th8,379.629,387.4 28.5%   
Avg. wages/employee Rs Th1,289.00-   
Avg. net profit/employee Rs Th1,388.71,835.8 75.6%   
INCOME DATA
Net Sales Rs m137,0161,320,816 10.4%  
Other income Rs m1,8770-   
Total revenues Rs m138,8931,320,816 10.5%   
Gross profit Rs m37,535361,706 10.4%  
Depreciation Rs m4,635106,763 4.3%   
Interest Rs m44625,943 1.7%   
Profit before tax Rs m34,330229,000 15.0%   
Minority Interest Rs m-881,040 -8.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-150,326 0.0%   
Tax Rs m11,536-2,796 -412.6%   
Profit after tax Rs m22,70782,510 27.5%  
Gross profit margin %27.427.4 100.0%  
Effective tax rate %33.6-1.2 -2,752.3%   
Net profit margin %16.66.2 265.3%  
BALANCE SHEET DATA
Current assets Rs m97,790892,074 11.0%   
Current liabilities Rs m53,872777,964 6.9%   
Net working cap to sales %32.18.6 371.0%  
Current ratio x1.81.1 158.3%  
Inventory Days Days8591 93.3%  
Debtors Days Days12196 126.4%  
Net fixed assets Rs m86,379431,408 20.0%   
Share capital Rs m9013,251 27.7%   
"Free" reserves Rs m105,7350-   
Net worth Rs m109,8441,467,176 7.5%   
Long term debt Rs m53,739675,363 8.0%   
Total assets Rs m224,3783,018,488 7.4%  
Interest coverage x77.99.8 793.1%   
Debt to equity ratio x0.50.5 106.3%  
Sales to assets ratio x0.60.4 139.6%   
Return on assets %10.33.6 287.2%  
Return on equity %20.75.6 367.6%  
Return on capital %21.24.9 430.0%  
Exports to sales %49.10-   
Imports to sales %7.40-   
Net fx Rs m53,5980-   
CASH FLOW
From Operations Rs m-3,690210,470 -1.8%  
From Investments Rs m-69,434-74,578 93.1%  
From Financial Activity Rs m58,126-252,473 -23.0%  
Net Cashflow Rs m-14,998-116,581 12.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 65.02 Rs / USD

Compare LUPIN LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare LUPIN LTD With: NOVARTIS  GLENMARK PHARMA  FRESENIUS KABI ONCO.  FULFORD INDIA  NATCO PHARMA  



Today's Market

Sensex Down Over 290 Points; Metal Stocks Witness Losses(11:30 am)

After opening the day in the red, Indian share markets continued to witness selling pressure on the back of North Korea tensions.

Related Views On News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Sep 22, 2017 01:38 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS